These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8154343)

  • 41. Isolation and characterization of hirudin from Hirudo medicinalis.
    Walsmann P
    Semin Thromb Hemost; 1991 Apr; 17(2):83-7. PubMed ID: 1771416
    [No Abstract]   [Full Text] [Related]  

  • 42. Anticoagulant peptides: nature of the interaction of the C-terminal region of hirudin with a noncatalytic binding site on thrombin.
    Krstenansky JL; Owen TJ; Yates MT; Mao SJ
    J Med Chem; 1987 Sep; 30(9):1688-91. PubMed ID: 3625715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sulphation of hirudin in BHK cells.
    Skern T; Bischoff R; Jallat S; Dott K; Ali-Hadji D; Clesse D; Kieny MP; Courtney M
    FEBS Lett; 1990 Nov; 275(1-2):36-8. PubMed ID: 2261997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The structural elements of hirudin which bind to the fibrinogen recognition site of thrombin are exclusively located within its acidic C-terminal tail.
    Chang JY; Ngai PK; Rink H; Dennis S; Schlaeppi JM
    FEBS Lett; 1990 Feb; 261(2):287-90. PubMed ID: 2107100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Recent developments in the biochemistry of hirudins].
    Walsmann P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):821-30. PubMed ID: 2483699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Basis for the reduced affinity of beta T- and gamma T-thrombin for hirudin.
    Stone SR; Hofsteenge J
    Biochemistry; 1991 Apr; 30(16):3950-5. PubMed ID: 2018764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The NMR solution structure of recombinant RGD-hirudin.
    Song X; Mo W; Liu X; Zhu L; Yan X; Song H; Dai L
    Biochem Biophys Res Commun; 2007 Aug; 360(1):103-8. PubMed ID: 17585879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
    Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
    Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Covalent linkage of recombinant hirudin to poly(ethylene terephthalate) (Dacron): creation of a novel antithrombin surface.
    Phaneuf MD; Berceli SA; Bide MJ; Quist WC; LoGerfo FW
    Biomaterials; 1997 May; 18(10):755-65. PubMed ID: 9158859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure-activity relationships of recombinant hirudins.
    Stürzebecher J; Walsmann P
    Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
    Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
    Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immobilized hirudin and hirudin-based peptides used for the purification of recombinant human thrombin prepared from recombinant human prothrombin.
    Fischer BE; Mitterer A; Schlokat U; Grillberger L; Reiter M; Mundt W; Dorner F; Eibl J
    Protein Expr Purif; 1996 Sep; 8(2):167-74. PubMed ID: 8812854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
    Stone SR; Le Bonniec BF
    J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Noncoded amino acids in protein engineering: Structure-activity relationship studies of hirudin-thrombin interaction.
    De Filippis V; Acquasaliente L; Pontarollo G; Peterle D
    Biotechnol Appl Biochem; 2018 Jan; 65(1):69-80. PubMed ID: 29230873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma.
    Lindhout T; Blezer R; Hemker HC
    Thromb Haemost; 1990 Nov; 64(3):464-8. PubMed ID: 2096492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrostatic interactions in hirudin-thrombin binding.
    Sharp KA
    Biophys Chem; 1996 Aug; 61(1):37-49. PubMed ID: 8855358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural and Functional Characterization of Hirudin P6 Derived Novel Bivalent Thrombin Inhibitors - Studying the Effect of Linker Length and Glycosylation on Their Function.
    Shabareesh P; Kaur KJ
    Chem Biol Drug Des; 2016 Jul; 88(1):129-41. PubMed ID: 26850929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular dynamics simulations of thrombin inhibitors at the S' subsites of thrombin.
    Yue SY; Konishi Y
    Drug Des Discov; 1994 Jul; 12(1):1-17. PubMed ID: 7578804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitor binding to thrombin: x-ray crystallographic studies.
    Banner DW; Hadváry P
    Adv Exp Med Biol; 1993; 340():27-33. PubMed ID: 8154341
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of the hirudin carboxy-terminal peptide 54-65 on the interaction of thrombin with platelets.
    Jandrot-Perrus M; Huisse MG; Krstenansky JL; Bezeaud A; Guillin MC
    Thromb Haemost; 1991 Sep; 66(3):300-5. PubMed ID: 1746000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.